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Abstract: Approximately 10 percent of the mouse genome consists of endogenous retroviruses 
(ERVs), relics of ancient retroviral infections that are classified based on their relatedness to 
exogenous retroviral genera. Because of the ability of ERVs to retrotranspose, as well as their cis-
acting regulatory potential due to functional elements located within the elements, mammalian 
ERVs are generally subject to epigenetic silencing by DNA methylation and repressive histone 
modifications. The mobilisation and expansion of ERV elements is strain-specific, leading to ERVs 
being highly polymorphic between inbred mouse strains, hinting at the possibility of the strain-
specific regulation of ERVs. In this review, we describe the existing evidence of mouse strain-specific 
epigenetic control of ERVs and discuss the implications of differential ERV regulation on epigenetic 
inheritance models. We consider Krüppel-associated box domain (KRAB) zinc finger proteins as 
likely candidates for strain-specific ERV modifiers, drawing on insights gained from the study of 
the strain-specific behaviour of transgenes. We conclude by considering the coevolution of KRAB 
zinc finger proteins and actively transposing ERV elements, and highlight the importance of cross-
strain studies in elucidating the mechanisms and consequences of strain-specific ERV regulation. 
Keywords: ERVs; epigenetic regulation; strain-specific; modifiers; metastable epialleles; KRAB zinc 
finger proteins; transgenes 
 
1. Introduction 
Endogenous retroviruses (ERVs), a subclass of transposable element (TE), constitute 
approximately 10 percent of the mouse genome and arise either as a result of the successful 
integration of an ancient exogenous retrovirus (XRV) into the germline of the host or, more 
commonly, due to the retrotransposition of a previously integrated proviral sequence [1,2]. ERVs are 
classified based on the sequence of their reverse transcriptase gene and their relatedness to the seven 
XRV genera—Gamma- and Epsilonretrovirus; Alpha-, Beta-, and Deltaretrovirus; and Spumaretrovirus—
into class I, II, and III ERVs, respectively [3–6]. In the mouse, class I ERVs include murine leukaemia 
viruses (MLVs), class II ERVs include early transposon/Mus musculus type D retrovirus (ETn/MusD) 
and intracisternal A-type particle (IAP) elements, and class III ERVs include mouse endogenous 
retrovirus type L (MERV-L) elements [5]. 
Full-length ERVs consist of 5’ and 3’ long terminal repeats (LTRs) that flank internal viral genes 
(gag, pol, and, in some elements, env) which are both essential and necessary for autonomous 
retrotransposition [7,8]. Non-autonomous elements, such as ETn elements, lack the reverse 
transcription and integrase machinery required for transposition and thus, mobilisation of these 
elements relies on trans-acting transposases encoded by other TEs. In fact, after IAPs, non-
autonomous ETn elements are responsible for the second highest number of murine germline 
mutations of any transposon type and mobilise using the machinery of autonomous MusD elements 
[9,10]. Similarly, the non-autonomous IΔ1-type IAP, which has a 1.9kb deletion in gag-pol, accounts 
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for the majority of IAP insertional mutations [11]. Whilst the majority of ERVs exist as solo LTRs 
which arise through inter-LTR homologous recombination, these fragmented elements still pose a 
significant threat to genomic integrity. This is due to the functional regulatory sequences contained 
within LTRs, as well as their mobilisation potential through “hijacking” the machinery of 
transposition-competent full-length elements [12]. In total, ERVs mainly of class I and II types are 
responsible for up to 12% of germline mutations in mice [11]. Given the mutagenic potential of ERVs, 
both full-length elements and solo LTRs are targeted for silencing via epigenetic mechanisms, as 
outlined in further detail below. 
In inbred laboratory strains of mice, there has been a historic, and ongoing, expansion of ERV 
families, most notably of IAP and ETn/MusD elements, which are highly polymorphic between 
strains [13–16]. The susceptibility of the mouse genome to IAP mobilisation is strain-specific, with 
84% of germline IAP mutations (for which a strain of origin for the TE mutation could be determined) 
occurring in the C3H genetic background [9]. Indeed, strain-specific diverse regions (SSDRs), which 
show a higher diversity between strains than is normally seen between mouse and rat and account 
for between 0.5% and 2.8% of the mouse genome, are enriched for recent long interspersed nuclear 
element (LINE) and LTR insertions [17,18]. While there is little evidence so far that strain-specific TE 
variants act as causal effectors of strain-specific gene expression changes or quantitative trait loci 
(QTL), it is perhaps notable that intronic TE variants are more frequently associated with 
differentially expressed genes than would be expected by chance [15]. 
The term “modifier gene” defines genetic variants which alter the phenotypic outcome of an 
independent locus, but which have no phenotypic consequence of their own [19,20]. Strain-specific 
morphological, physiological, and behavioural differences are well recognised, but the mechanisms 
underlying inter-strain variation and the causative modifier loci remain largely uncharacterised due 
to technical and practical limitations. 
In this review, we discuss the key players in the silencing of ERVs, the existing evidence for the 
mouse strain-specific epigenetic control of ERVs, and the implications of differential ERV regulation 
on epigenetic inheritance. We reflect on lessons learned from the strain-specific behaviour of 
transgenes and discuss the potential mechanisms by which the strain-specific epigenetic silencing of 
ERVs is likely to occur. 
2. Epigenetic Regulation of ERVs 
Specific ERV classes are silenced by distinct epigenetic mechanisms in the early embryo and 
embryonic stem cells (ESCs). In embryonic cells, class I and II ERVs are enriched for H3K9me3, a 
mark deposited by the histone methyltransferase SETDB1 [21,22]. These ERVs are targeted for 
silencing in a sequence-dependent manner by Krüppel-associated box domain zinc-finger proteins 
(KRAB-ZFPs), which make up a large family of DNA binding proteins whose sequence specificity is 
determined through their C-terminal zinc finger arrays [23,24]. Through their KRAB domain, KRAB-
ZFPs recruit KRAB-associated protein 1 (KAP1), which acts as a scaffold for other components of the 
transcriptional silencing machinery, including SETDB1, HP1 (heterochromatin protein 1), 
NuRD/HDAC (nucleosome remodelling and deacetylase complex), and DNA methyltransferases 
[25–27]. For a more detailed description of KRAB-ZFP structure and function, we refer the reader to 
the following comprehensive reviews [27,28]. In mouse ESCs and primordial germ cells (PGCs), 
whilst DNA methylation is dispensable for ERV silencing as evident from bulk ERV type analysis, 
knocking out SETDB1 or KAP1 results in the upregulation of several class I and II ERVs [21,22,29,30]. 
In contrast, DNA methylation is essential for ERV silencing in differentiated cell types and later 
embryonic time points, though the extent of this is not known [31–33]. The silencing mechanisms for 
class III ERVs are less clear; in ESCs, class III ERVs are largely devoid of H3K9me3 except at MERV-
Ls, whose silencing and H3K9me2/3 deposition is dependent on G9a/GLP activity [34,35]. A role for 
the lysine-specific histone demethylase LSD1/KDM1A in MERV-L silencing in early embryos and 
ESCs has been proposed, but is less well defined [36,37]. 
In the mouse, as in other mammals, there are tightly regulated periods of epigenetic 
reprogramming whereby epigenetic modifications are globally erased and developmental potency is 
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re-established. This occurs immediately post fertilisation in the zygote and in PGCs and is generally 
recapitulated in ESCs in vitro [38]. During development, the genome-wide removal of DNA 
methylation results in the transient transcriptional activation of certain classes of ERVs, notably class 
III MERV-Ls, which play a role in zygotic genome activation (ZGA) at the 2-cell stage in mice [39–
41]. Retrotransposition inhibition and the transcriptional control of other classes of ERVs is 
maintained during epigenetic reprogramming implicating additional silencing pathways [42–46]. 
Other epigenetic mechanisms associated with ERV silencing involve 3’ tRNA fragments [47], piRNA 
pathways [48], and histone variants [49–52]. 
3. Evidence of Strain-Specific ERV Control 
The high prevalence of polymorphic ERVs raises many questions about the similarities and 
differences in transposon regulation between strains. The strain-specific expansion of ERVs in inbred 
mice hints at the possibility of strain-specific ERV silencing, or lack thereof, and subsequent 
mobilisation. Thus far, no unbiased or genome-wide screens to assess strain-specific ERV control 
have been carried out. The few documented instances of strain-specific modifiers were identifiable 
due to obvious and observable phenotypic differences. These are discussed in more detail below. 
3.1. Dactylaplasia-Causing MusD Insertions at Fbxw4 
Dactylaplasia is an inherited limb malformation which manifests as the absence of phalangeal 
bones in the middle digits of each foot in mice. The first identified mutation (Dac1j) arose in the 
SM7B/SC inbred strain and was found to be a homozygous lethal dominant allele [53]; a second 
dactylaplasia-causing mutation (Dac2j) was reported several years later on the MRL/MpJ genetic 
background [54]. Fine mapping and sequencing experiments established that both Dac1j and Dac2j are 
due to independent, full length, highly similar (99.6% identical), and polymorphic MusD element 
insertions, which lie either 10kb upstream (Dac1j) or within an intron (Dac2j) of the Fbxw4 gene locus, 
a member of the F-box/WD40 gene family involved in protein ubiquitination and degradation [54–
57] (Figure 1a, top and middle panel). The mechanism by which these MusD insertions cause 
dactylaplasia remains unknown [56,57].  
The effects of both Dac1j and Dac2j were found to be modified by an unlinked allele Mdac (modifier 
of Dac), which resulted in highly polymorphic phenotypes between inbred mouse strains [53–55]. The 
strains carrying the Mdac allele are hypermethylated and enriched for H3K9me3 at the 5’ LTRs of 
Dac1j and Dac2j, resulting in the loss of aberrant MusD expression at the apical ectodermal ridge in the 
limb bud seen in mdac strains and enabling normal limb development to occur [56] (Figure 1a, bottom 
panel). The Mdac locus was first mapped to a 28Mb interval on Chromosome 13 and was later refined 
to a 9.4Mb region containing 125 genes, including many known to be important for limb 
development—e.g., Ror2, Msx2, Fgfr4, and Patched [55,56] (Figure 2). This 9.4Mb region contains a 
KRAB-ZFP cluster of six KRAB-ZFP genes which, given their known role in ERV epigenetic targeting, 
are possible Mdac candidates [58]. It is worth noting, however, that a recent study where this KRAB-
ZFP cluster (Chr13.1-cl KO) was deleted did not lead to a global upregulation of MusD elements in 
ESCs [59]. This is in line with the finding that a control MusD element was not differentially regulated 
according to the mdac/Mdac genotype [56]. 
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Figure 1. Schematics for the insertion sites of endogenous retroviruses (ERVs) subject to strain-specific 
regulation (upper panel) and the effects of strain-specific modifier activity (lower panel) for (A) Dac1j 
and Dac2j, (B) clf1, and (C) Stab2-IAP. Sticks with closed circles represent methylated CpGs in the long 
terminal repeat (LTR) of the ERV; sticks with open circles represent unmethylated CpGs. Black dotted 
lines depict introns; thick black lines depict intergenic regions. The information is based on the latest 
patch release of the 2011 mouse assembly on the UCSC Genome Browser (GRCm38.p6); the 
coordinates given are mm10. 
Viruses 2020, 12, 810 5 of 22 
 
3.2. Cleft Lip Palate-Causing IAP Insertions at Wnt9b 
Nonsyndromic cleft lip with palate (CL/P) defects arise when the medial and frontal nasal 
prominences fail to fuse; CL/P causes neonatal lethality in mice, as the pups are unable to suckle. 
CL/P spontaneously occurs with a 20–30% frequency in the inbred mouse strain A/WySn, making it 
a commonly used model to study clefting [60]. Similarly to the dactylaplasia phenotype, the CL/P 
phenotype in A/WySn mice involves two unlinked genes, a recessive mutation (clf1), and a second 
semi-dominant modifier locus (Clf2) [61]. The clf1 mutation was identified as an IAP element insertion 
into a ncRNA, C130046K22Rik, located 6.6kb downstream of Wnt9b [62,63] (Figure 1b, upper panel). 
The insertion is only present in “A” strains and is a IΔ1-type IAP, the same type responsible for the 
Agouti viable yellow (Avy) and Axin-fused (AxinFu) metastable epialleles (discussed below). Wnt9b has 
been implicated in clefting previously: Wnt9b null embryos have deficient growth of the facial 
prominences, resulting in CL/P, which possibly manifests via the downregulation of Fibroblast 
Growth Factor (FGF) signalling in these mutants [64]. 
In A/WySn embryos with CL/P, the 5’ LTR of the clf1 IAP element is unmethylated [63,65–67] 
(Figure 1b, lower panel). 5’ LTR initiated antisense IAP transcripts and reduced Wnt9b levels are 
detected in CL/P A/WySn embryos compared to phenotypically normal A/WySn embryos, but the 
mechanism by which this occurs is unknown [63,67]. On a C57BL/6J (B6J) genetic background with 
the Clf2 modifier, the clf1 IAP element is more highly methylated, no IAP transcripts are detectable, 
and Wnt9b expression is normal [66]. As assessed by Combined Bisulfite and Restriction Analysis 
(COBRA), phenotypically normal A/WySn embryos appear to exhibit variable DNA methylation at 
the 5’ LTR of the clf1 IAP element. This suggests this IAP is a metastable epiallele and it was thus 
redefined as Wnt9bIAP by Juriloff et al [63]. 
Once again, the modifier responsible for the strain-specific methylation of the CL/P-inducing 
IAP, Clf2, has not yet been identified but has been mapped to a 3Mb region on Chromosome 13; this 
region contains 48 genes and includes a known KRAB-ZFP cluster of more than 30 KRAB-ZFPs 
[58,66] (Figure 2). Many of the KRAB-ZFP genes in this cluster contain divergent non-synonymous 
single nucleotide polymorphisms (SNPs) between the B6J and A/WySn strains [28,66]. Though both 
are on Chromosome 13, this KRAB-ZFP cluster is distinct from that identified in the mapping 
experiments of the Mdac candidate. 
3.3. Non-Ecotropic ERV Activation Links to Lupus 
The mouse strains commonly used as models for human systemic lupus erythematosus (SLE)—
New Zealand Black (NZB), New Zealand White (NZW), and 129—have high gene expression and 
protein levels of non-ecotropic ERV (NEERV) envelope glycoprotein gp70, concomitant with 
nephritis. However, a causative link between NEERV dysregulation and lupus pathology has not 
been established, and the mechanism for NEERV dysregulation is unknown. Previously, 
independent QTL analyses in the NZB/NZW and 129 strains mapped the loci (Sgp3 in NZB and Gv-
1 in 129) responsible for the gp70 autoantigen expression to large intervals on Chromosome 13 [68,69]. 
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Figure 2. The mapped intervals of four strain-specific ERV modifiers—Mdac, Clf2, Snerv1 and Snerv2 
and Stab2-modifier — on Chromosome 13. The underlying genes are separated into Krüppel-
associated box domain zinc-finger protein (KRAB-ZFP) genes and non-KRAB-ZFP genes; the KRAB-
ZFP clusters are highlighted and named as in [59]. Multiple isoforms are not shown. 
A recent comparative RNA-seq study between B6J and C57BL/6N (B6N) found that the majority 
of differentially expressed loci between these two sub-strains were NEERVs; the ERV envelope 
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protein and NEERV gene expression were significantly higher in B6N compared to B6J [70]. F1 hybrid 
mice showed low NEERV gene expression and ERV envelope protein levels that were comparable to 
B6J mice, indicating the presence of a dominant NEERV repressor in the B6J sub-strain. A QTL 
analysis revealed a single QTL locus on Chromosome 13 responsible for NEERV dysregulation; an 
inter-strain comparison and copy number analysis revealed a 1Mb deletion specific to B6N in the 
mapped interval. This 1Mb region in B6J contains two genes, four non-coding RNAs, and four 
pseudogenes (Figure 2). The knockouts of the two genes in this interval on a B6J genetic background 
phenocopied the NEERV dysregulation seen in the B6N strain. The two genes are the KRAB-ZFP 
genes 2410141K09Rik and Gm10324, renamed suppressor of NEERV (Snerv) 1 and 2. 
The previously mapped intervals for Sgp3 and Gv-1 in NZB and 129, respectively, include Snerv1 
and Snerv2. Additionally, the 1Mb deletion in B6N also appears to be deleted in NZB and 129, 
indicating that the previously mapped Sgp3 and Gv-1 loci may be the same modifiers as Snerv1 and 
2. Complementation experiments found that hybrid F1 mice (Snerv1/2-/- X NZB/129) were unable to 
rescue the NEERV repression phenotype, indicating that the strain-specific absence of these KRAB-
ZFPs, previously identified as Sgp3 in NZB and Gv-1 in 129, may drive the NEERV dysregulation and 
lupus pathology in lupus-prone strains, NZB and 129. 
3.4. IAP-Driven Stabilin2 Expression in DBA/2J Mice 
Stabilin2 (Stab2) encodes a type I transmembrane receptor which functions via clathrin-mediated 
endocytosis as a scavenger receptor for hyaluronans (HA), heparin, and pro-collagen peptides, 
amongst other macromolecules [71,72]. The main phenotype of Stab2 null mice, which were 
generated on B6J and BALB/cJ genetic backgrounds, is a 10-fold higher plasma HA concentration 
compared to wild type [73,74]. Independently, one study reported that wild-type DBA/2J (DBA) mice 
have a more than 10-fold higher plasma HA concentration than 129S6 or B6J mice, a phenotype which 
was mapped to the Stab2 locus [75]. Recently, it was shown that a 5.5kb IΔ1-type IAP element inserted 
220bp upstream of the canonical Stab2 transcription start site (TSS), providing an alternative TSS 
which drives the ectopic expression of Stab2 [76] (Figure 1c, upper panel). The IAP element (Stab2-
IAP), alternative TSS, and ectopic Stab2 expression are unique to the DBA genetic background. 
In B6J x DBA (BxD) F1 hybrid heart tissue, IAP-driven Stab2 expression is completely abrogated, 
indicative of a single dominant modifier in the B6J strain targeting the Stab2-IAP for silencing and 
preventing aberrant transcription. A congenic line homozygous for the DBA-specific Stab2-IAP in an 
otherwise 129S6/Sv (129S6) genetic background exhibited Stab2 expression levels that were 
significantly reduced compared to DBA but that were higher than a pure 129S6 genetic background. 
The lack of the complete transcriptional repression of the IAP-driven transcripts suggests that an 
additional locus or loci are responsible for targeting the DBA-specific IAP on the 129S6 genetic 
background. The 5’ LTR of the Stab2-IAP is highly methylated on the DBA and 129S6 genetic 
background, as assessed by clonal bisulfite sequencing (75.7% vs. 85.0%, respectively), indicating that 
a mechanism besides DNA methylation may also be involved in the strain-specific behaviour of this 
IAP element [76] (Figure 1c, lower panel). The methylation status of the Stab2-IAP was not assessed 
on a B6J background. The small increase in DNA methylation at the Stab2-IAP on a 129S6 genetic 
background may be a secondary consequence of other repressive epigenetic modifications, such as 
increased H3K9me3, which prevent ectopic transcription initiating from the LTR. Besides DNA 
methylation, additional epigenetic modifications at the Stab2-IAP were not assayed. 
Utilising the BxD recombinant inbred lines and gene expression data from the Hybrid Diversity 
Panel, the most prominent trans expression QTL (eQTL) locus was mapped to Chromosome 13 and 
refined to 59.7–73Mb [76] (Figure 2). The region overlaps the modifiers (and KRAB-ZFP clusters) 
mapped for Mdac (56–65 Mb), Clf2 (64.95 -67.9 Mb) and Snerv1/2 (65.66–66.7 Mb). In the other three 
examples of strain-specific regulation discussed so far, the modifiers appear to be single dominant 
loci. This seems to hold true for the Stab2-IAP in a B6J F1 background. However, on a 129S6 F1 
background, the Stab2-IAP is not fully repressed, as assessed by the elevated Stab2 expression and 
the methylation status of the 5’ LTR. In this regard, the strain-specific modifier acting on Stab2-IAP is 
particularly interesting, as it exhibits both strain-specific absence/presence polymorphism (B6J and 
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129S6 vs. DBA) and a strain-specific mode of action (B6J vs. 129S6). It is worth pointing out that when 
a single locus is mapped, there may be multiple modifiers that are always inherited together capable 
of recognising the target ERV, making it seem like the Mendelian segregation of a single gene. This 
is especially pertinent given that all of the mapped intervals contain KRAB-ZFP clusters, which are 
known to expand through segmental duplication, resulting in individual KRAB-ZFPs with highly 
redundant roles [59]. 
3.5. Epigenetic Inheritance of Metastable Epialleles, Avy and AxinFu 
Metastable epialleles are regions of the genome which display variable epigenetic states between 
genetically identical individuals [77,78]. The most comprehensively studied metastable epialleles to 
date, Avy and AxinFu, result from the variable silencing of IAP element insertions upstream of, or 
within, endogenous gene loci, and were identified due to observable phenotypic differences between 
littermates [79–83]. Whilst no strain-specific modifiers have been identified that specifically act on 
the IAP elements responsible for the Avy or AxinFu alleles, it is clear that genetic background influences 
the heritability of these loci as well as the susceptibility of these alleles to environmental stimuli, two 
features for which these loci are particularly well known. 
The Avy-causing IAP insertion first arose spontaneously on a C3H/HeJ (C3H) genetic background 
in pseudoexon 1A of the coat colour gene Agouti, 100kb upstream of the coding exons [79,84] (Figure 
3a, upper panel). In wild-type mice, the Agouti expression is regulated by a hair cycle-specific 
promoter; transient expression at the beginning of each hair follicle cycle results in a sub-apical 
yellow band on an otherwise black hair follicle and the “agouti” coat pattern. In Avy mice, 
transcription originating from a cryptic promoter within the LTR of the IΔ1-type IAP element drives 
the ectopic expression of Agouti (Figure 3a, lower panel). The excess paracrine signalling molecule 
causes hair follicle melanocytes to constitutively synthesise yellow pigment (phaeomelanin), 
resulting in mice with yellow coats as well as adult-onset obesity, diabetes, and an increased 
susceptibility to tumours [85,86]. Isogenic individuals have variable DNA methylation at the IAP 
element, which inversely correlates with ectopic Agouti expression levels: highly-methylated 
individuals retain endogenous levels of expression and are indistinguishable from wild type (termed 
pseudoagouti); lowly-methylated individuals have high levels of ectopic expression and have a 
yellow coat, diabetes, and obesity; intermediately methylated individuals have an intermediate 
mottled coat-colour phenotype [80,84] (Figure 3a, lower panel). 
Similarly, the AxinFu allele resulted from a spontaneous IΔ1-type IAP element insertion in the 
sixth intron of Axin1 in the Bussey Institution stock of mixed genetic backgrounds [81,82] (Figure 3b, 
upper panel). At a low rate, the intronic IAP causes aberrant splicing, which results in both wild-type 
and mutant transcripts which contain the IAP; the inclusion of the AxinFu IAP in the mRNA is 
predicted to generate a truncated AXIN1 protein [82] (Figure 3b, lower panel). Transcripts initiating 
within 100bp downstream of the 3’ LTR of the AxinFu IAP have also been detected and may result in 
truncated peptides consisting of intron 6 and exons 7–10 [83]. The resultant kinked tail phenotype is 
attributed to the abnormal development of the posterior somites and axial duplications, which leads 
to vertebral fusions via atypical Wnt signalling [82,83]. Among isogenic individuals, tails range from 
kinked to completely normal, with the phenotypic severity inversely correlating with the DNA 
methylation status of the intronic AxinFu IAP element [83] (Figure 3b, middle and lower panels). 
Hybrid experiments to assess whether the Avy mutation was pleiotropic provided the first 
evidence that the Avy IAP was sensitive to genetic background; 12% of the B6JxVY-Avy hybrids were 
pseudoagouti, compared to 58% of the AKR/LwNIcr (AKR)xVY-Avy hybrids [87] (Figure 4a, lower 
panel). This may be indicative of an AKR-specific modifier(s) that more robustly recognises the Avy 
IAP for silencing and “pushes” the offspring towards the pseudoagouti end of the phenotypic 
spectrum. Subsequent studies showed that the phenotypic distribution and physiological outcomes 
of Avy mice shifted dependent on genetic background [86,88–91]; similar findings have been reported 
for the AxinFu locus [92,93]. In addition, the phenotypic shifts in the offspring of Avy dams subjected 
to methyl-supplemented diets differ depending on the genetic background of the dam, likely 
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reflecting differences in methyl metabolism between strains [90,91]. Figure 4a summarises the 
breeding experiments on Avy conducted by Wolff spanning almost 30 years. 
 
Figure 3. Schematics depicting the insertion sites of the metastable epialleles (A) Avy and (B) AxinFu. 
Upper panel shows the intracisternal A-type particle (IAP) insertion relative to the affected gene; 
lower panel shows the functional consequence of the variably methylated IAP element. Coordinates 
are mm10. Sticks with closed circles represent methylated CpGs in the LTR of the ERV; sticks with 
open circles represent unmethylated CpGs. Black dotted lines depict introns; thick black lines depict 
intergenic regions. 
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Both the Avy and AxinFu alleles display strain-specific epigenetic inheritance across generations 
(Figure 4b). On a B6J genetic background, Avy displays partial inheritance when transmitted 
maternally, whilst the AxinFu allele on a 129P4/RfRk (129P4) genetic background is inherited upon 
both maternal and paternal transmission [80,83]. Interestingly, Avy also displays paternal inheritance 
when Avy/a B6J males are crossed with AxinFu/+ 129P4 females (Figure 4b, upper panel). Conversely, 
AxinFu is no longer paternally transmitted when AxinFu/+ 129P4 males are crossed with Avy/a B6J 
females, indicating that the inheritance of the AxinFu allele is strain-specific, rather than an intrinsic 
property of the locus [83] (Figure 4b, lower panel). These findings suggest that paternally inherited 
alleles are subject to the full erasure of DNA methylation during epigenetic reprogramming by B6J-
fertilised oocytes, but not 129P4-fertilised oocytes. Indeed, immediately following fertilisation and in 
line with the rest of the genome, the paternal Avy allele undergoes rapid demethylation, whereas the 
maternal Avy allele does not in the B6J strain [94–96]. However, importantly, both the paternal and 
maternal alleles exhibit a comparable absence of DNA methylation at Avy at the blastocyst stage, 
which suggests that DNA methylation is not the inherited epigenetic mark [96]. 
Our group recently performed a genome-wide systematic screen of IAP elements in B6J to 
identify novel metastable epialleles, which we termed variably methylated IAP elements (VM-IAPs) 
[97]. Although VM-IAPs are not commonly associated with transcriptional changes, nor do they 
retain a memory of the parental methylation level in the offspring, we do find that VM-IAPs are 
sensitive to genetic background and parent-of-origin effects, in line with the Avy and AxinFu alleles 
[98]. Given that VM-IAPs are naturally occurring alleles that are polymorphic between strains, they 
represent an attractive model in which to study the modifiers and mechanisms involved in the strain-
specific epigenetic regulation of IAP elements. Taken together, in depth cross-strain analyses on Avy, 
AxinFu, and VM-IAPs are likely to provide mechanistic insight into the establishment and 
maintenance of these unique loci. 
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Figure 4. The effect of genetic background on the phenotypic spectrum and inheritance of Avy upon 
maternal or paternal transmission. (A—upper) Maternal and paternal transmission of the Avy allele 
on VY/Wf (VY), YS/ChWf (YS), or AT/Wf (AT) genetic backgrounds. The percentage of pseudoagouti 
(PA) offspring depends upon the maternal coat colour phenotype, but not the paternal coat colour 
phenotype. Paternal transmission of Avy results in a higher percentage of PA offspring than the 
maternal transmission of Avy. Both maternally and paternally transmitted alleles are sensitive to 
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genetic background effects, albeit in different ways. (A—lower) Paternal transmission of Avy is largely 
influenced by the genetic background of the dam. Paternal coat colour information is not included, as 
it is not available for all of the inter-strain crosses. B6J = C57BL/6J; AKR = AKR/LwNIcr. The data 
shown in the upper and lower panel are combined (based on the genotype and parent-of-origin) and 
adapted from [87,89,90]. (B—upper) On a C57BL/6J background, the maternal coat colour phenotype 
influences the coat colour of the Avy/a offspring, but the paternal coat colour phenotype has no effect 
on the phenotypic distribution of the offspring. When the Avy allele is paternally inherited through a 
129P4/RrRk-fertilised oocyte, the paternal coat colour phenotype influences the coat colour of the Avy/a 
offspring; the percentage of PA and mottled is increased after passage through a 129P4/RrRk-fertilised 
oocyte compared to a C57BL/6J-fertilised oocyte. (B—lower) On a 129P4/RrRk background, the 
maternal and paternal tail kink phenotype influences the tail kink phenotype in the AxinFu/+ offspring. 
The phenotypic distributions are different upon the maternal versus paternal transmission of the 
allele. When the AxinFu allele is paternally inherited through a C57BL/6J-fertilised oocyte, the tail kink 
phenotype of the sire has no bearing on the phenotypic distribution in the AxinFu/+ offspring. The data 
shown in the upper and lower panel are adapted from [80,83]. Pedigrees: circle—female; square—
male; diamond—unspecified. 
4. Lessons from Transgenes 
The similarities between metastable epialleles and the epigenetic targeting of transgenes have 
been highlighted previously [77,78,99–102]. Methylated transgenes and endogenous metastable 
epialleles are loci with varying degrees of DNA methylation that can exhibit parent-of-origin effects 
upon transmission. In addition, the genetic background in which transgenes and metastable 
epialleles are studied affects their methylation state and heritability, suggesting that strain-specific 
modifiers are acting on these loci. 
The strain-specific silencing of ERVs is particularly reminiscent of the decades-spanning work 
on a transgene designed to study the rearrangement of immunoglobulin genes in the Storb lab. The 
transgene was designed as a marker of V-J recombination: the construct contains a mouse 
metallothionein-1 promoter upstream of the bacterial xanthine/guanine phosphoribosyltransferase (gpt) 
gene, whose translation is dependent on V-J rearrangement to form an upstream in-frame initiation 
codon [103]. The transgene was named HRD (heavy chain enhancer, rearrangement by deletion), and 
was found to recombine 100% of the time in a transfected pre-B cell line [103,104]. When maintained 
on the DBA genetic background, the HRD transgene is unmethylated. Upon crossing the founder 
transgenic mice to B6J, the HRD transgene becomes highly methylated and no longer undergoes V-J 
recombination in the lymphoid organs of the offspring [105]. The further crossing of B6J mice with 
the HRD transgene to DBA or SJL/J (SJL) mice resulted in offspring with a methylated HRD 
transgene. Crossing these F1 hybrids (B6Jx DBA or SJL) back to DBA or SJL mice resulted in offspring 
(N1) with an unmethylated, partially methylated, or methylated HRD transgene, suggestive of a 
dominant B6J modifier that had been lost in some of the backcrossed N1 individuals. The single 
dominant B6J allele responsible for HRD transgene methylation, Strain-specific modifier 1 in C57BL/6J 
(Ssm1b), was found to be concordant with the B allele of Fv-1, a resistance allele to the Friend 
leukaemia virus, which mapped Ssm1b to Chromosome 4 [105]. Ssm1b was later fine-mapped to a 
0.5Mb interval on Chromosome 4, a region containing ~12 genes, six of which are KRAB-ZFPs [106]. 
Several overlapping bacterial artificial chromosomes (BACs) covering the mapped region were 
injected into fertilised eggs carrying the HRD transgene on an unmethylated genetic background 
(C3H x DBA hybrids). Two of the BACs containing a single gene in common resulted in the 
methylation of the HRD transgene, enabling the identification of Ssm1b as Zfp979 (NCBI designation 
is 2610305D13Rik) [106]. 
Zfp979 has a KRAB-A box and three functional C2H2 zinc fingers interspersed with three non-
functional zinc fingers. It resides in a cluster which contains 20 other KRAB-ZFPs on Chromosome 4. 
Zfp979 is widely expressed during embryonic development until embryonic day 8.5 (E8.5). Whilst 
ESCs on a DBA background have 0% DNA methylation at the HRD transgene, B6J ESCs have ~40% 
DNA methylation, indicating that the methylation of the HRD transgene likely occurs peri-
implantation, coincidental with the rest of the genome [107]. In a B6J or hybrid BxD background, 
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methylation at the HRD transgene increases from 40% to almost 100% between E8.5 and E9.5 and 
relies on the de novo methyltransferase DNMT3B [106]. The direct binding of ZFP979 to the HRD 
transgene and the existence of a ZFP979:KAP1 interaction have not yet been shown. A recent analysis 
of KRAB-ZFP clusters established that ZFP979/2610305D13Rik binds to IAPEY-int elements [59]. 
Ssm1b was originally identified due to the differential methylation of the HRD transgene in B6J 
(methylated) and DBA (unmethylated) genetic backgrounds. In total, when maintained on an F1 
background with DBA or SJL, the HRD transgene is methylated in seven strains of mice (C57BL/6J, 
FVB/NJ, C57L/J, LP/J, 129/SvJ, BALB/cJ, and A/J) and unmethylated in six strains of mice (DBA/2J, 
C3H/HeJ, SJL/J, CBA/J, SM/J, and AKR/J) [108]. The reference genomes for 16 strains were recently 
generated but there remain significant gaps in this region, likely due to the repetitive nature of the 
KRAB-ZFPs within this cluster, which are predicted to have arisen through segmental gene 
duplications [17,59,109]. This makes inter-strain sequence alignments of Zfp979 currently impossible. 
The generation of new reference genomes using long-read sequencing technologies will alleviate 
these issues and enable inter-strain comparisons at KRAB-ZFP clusters and other repeat-dense 
regions in the future. 
Indeed, the variable epigenetic state of both transgenes and metastable epialleles has been 
utilised to screen for modifiers involved in their epigenetic targeting: large-scale N-ethyl-N-
nitrosourea (ENU) mutagenesis screens have identified dominant and recessive genes capable of 
modifying GFP transgene variability in mice [102,110–116]. The hits from these screens have been 
named Modifiers of Murine Metastable Epialleles (Mommes), and the effect of some of these mutants on 
the phenotypic spectrum of Avy has been assessed [111,112]. Many of the candidates from the screen 
are known components of the ERV epigenetic silencing pathway, but it is not yet known if, and to 
what extent, these modifiers act in a strain-specific manner. In this regard, a screen focussing on the 
strain-specific modifiers of ERV silencing would be timely. 
5. KRAB-ZFPs as Effectors of Strain-Specific ERV Regulation 
Thus far, the most compelling examples of strain-specific ERV regulation involve IΔ1-type IAP 
elements, with the exception of the dactylaplasia-causing MusD insertion at Fbxw4. This is perhaps 
unsurprising, given the strain-specific expansions of IAP and MusD/ETn elements [9,11,13,15]. Whilst 
the two IΔ1-type IAP elements whose modifiers map to overlapping regions, clf1 and Stab2-IAP, are 
permissive in different strains, they are both targeted for silencing on a B6J genetic background, 
raising the possibility that their respective modifiers, Clf2 and Stab2-modifier, may in fact be the same 
(Table 1). As these strain-specific modifiers have been discovered due to observable phenotypes 
rather than specially designed screens, only dominant-acting alleles have been detected so far. Aside 
from the NEERV effectors, 2410141K09Rik and Gm10324, specific modifiers for the other ERVs subject 
to strain-specific regulation are yet to be identified. It is worth noting that many of the modifiers 
linked to strain-specific ERV regulation reside on Chromosome 13 and overlap known KRAB-ZFP 
clusters, one of which includes KRAB-ZFPs Rsl1 and Rsl2 (Figure 2 and Table 1) [66,70,76,117]. Rsl1 
and Rsl2 are strain-specific KRAB-ZFPs that regulate sexually dimorphic gene expression in the liver. 
One of the target genes of Rsl1, sex-limited protein (Slp), lies 2kb downstream of an ancient ERV 
[118,119]. In KAP1 knockout livers, there is an upregulation of Rsl1/Rsl2-target cytochrome P450 
genes, implicating the KRAB-ZFP/KAP1 pathway, with its already established role in ERV silencing, 
in the functional mechanism of RSL1 and RSL2 [27,120]. The KRAB-ZFP cluster (Chr13.2-cl) 
containing Rsl1 and Rsl2 has previously been identified as being highly variable between mouse 
strains [121]. It is possible that certain clusters contain KRAB-ZFPs with particularly rapid evolution 
in response to the amplification of active ERV elements, making them more polymorphic across 
mouse strains than other clusters. This may explain the strain-specific modifiers mapping 
predominantly to Chr13.2-cl, as well as the Ssm1b cluster, Chr4-cl. 
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Table 1. Overview of mapped strain-specific modifiers. 
Disru
pted 
Locus 
(ERV 
Type) 
Docum
ented 
Strains 
with 
ERV 
Mutatio
n  
Strain-
Specific 
Phenoty
pe 
Dominant 
Modifier 
Documented Permissive 
Strains 
Docum
ented 
Repress
ive 
Strains 
Coordinates of 
Modifier Locus 
(mm10) 
Refere
nces 
Dac1j/2j 
(Mus
D) 
Dac1j – 
SM/Ckc 
Dac2j – 
MRL/M
pJ 
 
Dactylap
lasia 
Mdac 
BALB/cJ, A/J, 129/J, 
SM/Ckc, LG/Ckc, 
CBA/J, 
C3H/J, 
C57BL/
6J, 
DBA/2J, 
AKR/J, 
SWR/J 
chr13:56–65Mb 
[54–
56] 
clf1 
(IΔ1-
type 
IAP) 
A/HeJ, 
A/WyS
nJ, A/J 
Cleft lip 
with 
palate 
Clf2 “A” strains 
C57BL/
6J 
chr13:64.95–67.9Mb 
[63,66,
122] 
NEER
Vs 
- 
NEERV 
dysregul
ation 
and 
lupus 
patholog
y 
Snerv1 and 2 C57BL/6N, 129S1/Sv, NZB 
C57BL/
6J 
chr13:65.66–66.7Mb [70] 
Stab2-
IAP 
(IΔ1-
type 
IAP) 
DBA/2J 
Elevated 
plasma 
HA 
Stab2-
modifier 
DBA/2J 
C57BL/
6J, 
129S6/S
v 
chr13: 59.7–73Mb [76] 
HRD 
transg
ene 
- 
Transge
ne no 
longer 
undergo
es V-J 
recombi
nation 
Ssm1b 
DBA/2J, C3H/HeJ, SJL/J, 
CBA/J, SM/J, AKR/J 
C57BL/
6J, 
FVB/NJ, 
C57L/J, 
LP/J, 
129/SvJ, 
BALB/cJ
, A/J 
chr4: 147.4–
147.9Mb 
[108,10
9, 
111] 
KRAB-ZFPs are attractive candidates for strain-specific modifiers of ERVs due to the sequence 
specificity endowed by their C-terminal ZFPs, which are under strong positive selection [123–125]. 
Indeed, it is worth noting that many of the ERVs subject to strain-specific regulation are the same 
type of TE (IΔ1-type IAP: clf1, Stab2-IAP, Avy, and AxinFu), providing support for the role of sequence 
in the strain-specific epigenetic targeting of these elements. Furthermore, the positive correlation that 
exists between the number of LTR retrotransposons and the number of zinc finger domains across 
mammalian species is indicative of concurrent waves of KRAB-ZFP and TE expansion [124,125]. The 
varying KRAB-ZFP gene content between strains, and even sub-strains of mice with less than 75 years 
divergence in the case of B6N and B6J, may underlie differing ERV activity and epigenetic regulation 
between strains of inbred laboratory mice [17,70,126,127]. In particular, the C3H strain is particularly 
susceptible to IAP mobilisation, and it is tempting to speculate that this may be explained by a KRAB-
ZFP cluster or gene deletion, as has occurred in the B6N, 129, and NZB strains, causing NEERV 
dysregulation [9,70]. The coexistence of strain-specific ERVs and strain-specific KRAB-ZFPs provides 
intriguing complexity to the KRAB-ZFP/TE coevolution debate in light of the non-mutually exclusive 
“arms race” and “domestication” models [27,28,128]. Future attempts to functionally characterise 
strain-specific KRAB-ZFPs in detail may be difficult. In addition to the high prevalence of gaps 
currently in the reference genomes at KRAB-ZFP clusters and repetitive regions, the high level of 
redundancy in the KRAB-ZFP-targeting of ERVs will make the identification and validation of 
candidate modifiers challenging [23,125,129]. This high level of redundancy may explain why KRAB-
ZFPs were not identified in the Mommes mutagenesis screen [102,116]. 
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It is not yet clear whether modifier loci are required for the establishment or maintenance of 
strain-specific epigenetic states at ERVs and transgenes. The identification and emphasis of KRAB-
ZFPs as strain-specific modifiers so far in this review suggests the focus may be on the strain-specific 
“establishment” of an epigenetic state, although some KRAB-ZFPs are known to play a protective 
role maintaining germline-derived DNA methylation marks during early embryonic development, 
notably ZFP57 and ZFP445 at imprinted loci [32,130–132]. Whilst 75% of ZFP57 binding sites are 
located in ERVs, the loss of this protein does not affect H3K9me3 deposition or DNA methylation at 
ERVs, nor does it lead to the loss of transcriptional repression of ERVs in ESCs [130,131,133]. This 
perhaps reflects the highly redundant nature of KRAB-ZFP-mediated ERV repression, or it may 
suggest that ZFP57 does not play a role at these TEs. Interestingly, instances of strain-specific ZFP57 
binding have been reported previously, conferred by genetic variation either in the ZFP57 binding 
motif itself or in neighbouring regions between strains, causing strain-specific differential 
methylation and subsequent ZFP57 binding [131]. Recently, the strain-specific loss of imprints in 
ESCs (129 v B6J) was mapped by QTL analysis to an interval spanning 52Mb-67.7Mb on Chromosome 
13, overlapping entirely or partially with the Mdac, Clf2, Snerv1/2, and Stab2-modifier loci [134]. 
Needless to say, the establishment of a strain-specific epigenetic state may occur via mechanisms 
outside of the KRAB-ZFP targeting pathway. Whilst our understanding of these processes is limited, 
it is possible that strain-specific epigenetic states could arise through the strain-specific protection (by 
KRAB-ZFPs or other proteins) or the strain-specific removal of epigenetic modifications during 
epigenetic reprogramming or at other time points in development. 
6. Concluding Remarks 
It is well established that the genetic background of mouse models can result in large phenotypic 
differences not attributable directly to the phenotype-associated genetic locus itself. Historically, 
these strain differences have been largely overlooked due to the technical challenges associated with 
identifying the underlying modifier genes. This has resulted in specific strains of mice being used in 
the study of certain traits, as is the case with the “A” strain mice and clefting. We note that while 
attention to genetic background as a variable across experiments is necessary to ensure experimental 
reproducibility as well as cross-strain, and potentially cross-species, generalisability, we hope that 
here we have emphasised the biological and mechanistic value of cross-strain experiments. 
Currently, the annotations of KRAB-ZFP clusters are poor even in the C57BL/6J reference genome. 
Advances in long-read sequencing technologies and the resultant high-quality mouse strain reference 
genomes with full coverage over KRAB-ZFP clusters and their target TEs will be required to enable 
large-scale inter-strain experiments and provide further mechanistic insight into the complex 
relationship between repetitive elements, the KRAB-ZFP machinery, and their coevolution. 
The strain-specific modifiers outlined in this review were identified due to observable 
phenotypic differences between permissive and repressive strains. The extent to which polymorphic 
ERVs, and indeed polymorphic ERV regulation, act as drivers of phenotypic variation between 
inbred mouse strains remains unclear. However, it is important to note that inbred laboratory mouse 
strains suffer from severe inbreeding depression, which may put an unusual strain on the host 
defence mechanisms against TE mobilisation. Experiments using wild-derived mice alongside 
laboratory strains would help elucidate whether these effects are reflective of host-TE dynamics in 
natural populations. Additionally, the studies discussed in this review serve as an important 
reminder that seemingly complicated epigenetic phenomena are sometimes explained by underlying 
genetic differences, highlighting the mutual dependence and interrelatedness of genetic and 
epigenetic pathways. 
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